Upon abstract acceptance, all posters must be uploaded and recorded on VoiceThread by January 26, 2026 at 5 p.m. All posters that are narrated on VoiceThread by the deadline will be officially listed ...
Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...
SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elicio Therapeutics, a next generation immunotherapy company, today announced virtual poster presentations for the Society for Immunotherapy of Cancer’s (SITC) ...
Antisense Therapeutics, an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a virtual poster presentation on the ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Ashvattha Therapeutics, a clinical-stage biotech company focused on novel hydroxyl dendrimer therapeutics (HDTs) to treat unmet medical needs in oncology, ocular ...
Since fellows in the UW Science Initiative’s Learning Actively Mentoring Program (LAMP) could not present their final poster research in person, the program’s director, Rachel Watson, led participants ...
Labroots was founded in 2008 to create a virtual space for scientists across academia and industry to share their research and connect with one another. While we’ve been around for a while, the ...
Six industry sponsored abstracts regarding Genmab and Genmab partnered programs selected for presentation at ASCO20 Virtual Scientific Program, including data from the epcoritamab (DuoBody®-CD3xCD20) ...
ENGLEWOOD CLIFFS, N.J., Feb. 8, 2021 /PRNewswire/ -- Enzychem Lifesciences (KOSDAQ: 183490), a biopharmaceutical company developing innovative medicines to improve the lives of patients with cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results